Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2349 Target Snapshot

Phosphorylase b kinase gamma catalytic chain, liver/testis isoform · SINGLE PROTEIN · Homo sapiens

1,598Compounds
257Assays
15Approved Drugs
1,002.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P15735. Use UniProt P15735 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P15735 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Phosphorylase b kinase gamma catalytic chain, liver/testis isoform as ChEMBL target CHEMBL2349, mapped to UniProt P15735. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2349
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P15735
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Phosphorylase b kinase gamma catalytic chain, liver/testis isoform is the right protein anchor across sources, using UniProt P15735 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPhosphorylase b kinase gamma catalytic chain, liver/testis isoform
UniProt AccessionP15735
Component TypeProtein
Sequence Length406 aa

Phosphorylase b kinase gamma catalytic chain, liver/testis isoform

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Phosphorylase b kinase gamma catalytic chain, liver/testis isoform, mapped to UniProt P15735. Sequence length is 406 aa.

Mapped IDP15735
Review namePhosphorylase b kinase gamma catalytic chain, liver/testis isoform
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

15
Approved
5
Phase III
11
Phase II
7
Phase I
Assay Mix

Activity Type Distribution

IC5024.0
KI592.0
KD386.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL388978 9.85 Kd 0.14 Preclinical
CHEMBL388978 9.47 IC50 0.336 Preclinical
CHEMBL603469 8.77 Kd 1.7 Clinical
CHEMBL535 8.23 Kd 5.9 Approved
CHEMBL2151321 8.21 IC50 6.1 Preclinical
CHEMBL509032 8.1 Ki 7.943 Preclinical
CHEMBL2001751 7.9 Ki 12.59 Preclinical
CHEMBL509032 7.89 Kd 13.0 Preclinical
CHEMBL1990885 7.8 Ki 15.85 Preclinical
CHEMBL5653589 7.75 Kd 17.58 Preclinical
Distribution

pChEMBL Value Distribution

37
5.0
73
5.5
45
6.0
24
6.5
11
7.0
4
7.5
5
8.0
2
8.5
5
9.0
2
9.5
pChEMBL
Approved Drugs

Approved Drugs

GILTERITINIB
CHEMBL3301622
Approved 2018
BRIGATINIB
CHEMBL3545311
Approved 2017
MIDOSTAURIN
CHEMBL608533
Approved 2017
NINTEDANIB
CHEMBL502835
Approved 2014
AFATINIB
CHEMBL1173655
Approved 2013
AFATINIB DIMALEATE
CHEMBL2105712
Approved 2013
RUXOLITINIB
CHEMBL1789941
Approved 2011
NILOTINIB
CHEMBL255863
Approved 2007
SUNITINIB
CHEMBL535
Approved 2006
Assay Landscape

Assay Landscape

257
Total Assays
128
Tested Compounds
2
Assay Types
Binding — 256 assays, 57 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 178 34 6.8
assay format 42 1 6.7
subcellular format 24 20 5.9
cell-based format 12 2 7.1
Functional — 1 assays, 128 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 128 5.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine